{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:51:03Z","timestamp":1789775463917,"version":"4.0.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/olq.0b013e3182631c9f","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T03:19:34Z","timestamp":1357183174000},"page":"813-821","source":"Crossref","is-referenced-by-count":47,"title":["Retrospective Analysis of Antimicrobial Susceptibility Trends (2000\u20132009) in Neisseria gonorrhoeae Isolates from Countries in Latin America and the Caribbean Shows Evolving Resistance to Ciprofloxacin, Azithromycin and Decreased Susceptibility to Ceftriaxone"],"prefix":"10.1097","volume":"39","author":[{"given":"Stefania","family":"Starnino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Galarza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Elena Trigoso","family":"Carvallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele Schwartz","family":"Benzaken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora Maldonado","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga Marina Sanabria","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina Llop","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis Portilla","family":"Carbajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Borthagaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Payares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne R.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210213","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/eri.09.63","article-title":". Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.","volume":"7","author":"Tapsall","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R2-14-20210213","doi-asserted-by":"crossref","first-page":"606","DOI":"10.7326\/0003-4819-148-8-200804150-00005","article-title":"Emerging antimicrobial resistance in Neisseria gonorrhoeae: Urgent need to strengthen prevention strategies.","volume":"148","author":"Workowski","year":"2008","journal-title":"Ann Intern Med"},{"key":"R3-14-20210213","first-page":"415","article-title":"The gonococcus fights back: Is this time a knock out Sex Transm I","volume":"86","author":"Lewis","year":"2010","journal-title":"nfect"},{"key":"R4-14-20210213","first-page":"1","article-title":"Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006.","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5-14-20210213","first-page":"332","article-title":"Update to CDCs sexually transmitted diseases treatment guidelines, 2006: Fluoroquinolones no longer recommended for treatment of gonococcal infections.","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R6-14-20210213","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/sti.2004.012781","article-title":"BASHH guideline for gonorrhoea.","volume":"80","author":"Bignell","year":"2004","journal-title":"Sex Transm Infect"},{"key":"R7-14-20210213","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14656560902731993","article-title":"The use of cephalosporins for gonorrhea: The impending problem of resistance.","volume":"10","author":"Barry","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"R8-14-20210213","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":". Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea Detailed characterization of the first strain with high-level resistance to ceftriaxone.","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-14-20210213","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMp1112456","article-title":"The emerging threat of untreatable gonococcal infection.","volume":"366","author":"Bolan","year":"2012","journal-title":"N Engl J Med"},{"key":"R10-14-20210213","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","article-title":". Threat to cefixime treatment of gonorrhea.","volume":"13","author":"Lo Yokoi","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"RR-12","key":"R16-14-20210213","first-page":"1","article-title":"Centers for Disease control and prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010.","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R17-14-20210213","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jac\/dkq476","article-title":". An evaluation of gentamicin susceptibility Neisseria gonorrhoeae isolates in Europe.","volume":"66","author":"Chisholm","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R18-14-20210213","first-page":"6","article-title":"Cephalosporin resistant N.","volume":"88","author":"Ross","year":"2012","journal-title":"gonorrhoeae: time to consider gentamicin Sex Transm Infect"},{"key":"R20-14-20210213","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00007435-200109000-00008","article-title":". Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998.","volume":"28","author":"Dillon","year":"2001","journal-title":"Sex Transm Dis"},{"key":"R21-14-20210213","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00007435-200305000-00012","article-title":". High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998.","volume":"30","author":"Sosa","year":"2003","journal-title":"Sex Transm Dis"},{"key":"R22-14-20210213","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/jac\/37.4.839","article-title":". The first molecular characterization of tetracycline-resistant Neisseria gonorrhoeae from Uruguay.","volume":"37","author":"Marquez","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"R23-14-20210213","first-page":"6","article-title":". Identification of penicillinase-producing Neisseria gonorrhoeae (PPNG) in Chile during clinical and micro-biological investigations of gonococcal susceptibility to antimicrobial agents.","volume":"63","author":"Moreno","year":"1987","journal-title":"Genitourin Med"},{"key":"R24-14-20210213","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.olq.0000187231.28812.29","article-title":". Challenge in the control of gonorrhea in South America and the Caribbean: Monitoring the development of resistance to antibiotics.","volume":"33","author":"Dillon","year":"2006","journal-title":"Sex Transm Dis"},{"key":"R25-14-20210213","first-page":"ii7","article-title":"Galban E, et al..","volume":"87","author":"Garcia","year":"2011","journal-title":"STI management and control in Latin America: where do we stand and where do we go from here Sex Transm Infect"},{"key":"R26-14-20210213","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00007435-200102000-00004","article-title":". Neisseria gonorrhoeae resistant to ciprofloxacin: first report in Cuba.","volume":"28","author":"Llanes","year":"2001","journal-title":"Sex Transm Dis"},{"key":"R27-14-20210213","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jac\/dkg043","article-title":". Antimicrobial resistance of Neisseria gonorrhoeae in the municipality of Moron, Cuba: Emergence of isolates with intermediate resistance to fluoroquinolones.","volume":"51","author":"Llanes","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"R28-14-20210213","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/sti.77.1.77","article-title":". Emergence of high level ciprofloxacin resistant Neisseria gonorrhoeae strain in Buenos Aires, Argentina.","volume":"77","author":"Fiorito","year":"2001","journal-title":"Sex Transm Infect"},{"key":"R30-14-20210213","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/mcpr.1998.0216","article-title":". A PCR assay for discriminating Neisseria gonorrhoeae beta-lactamase-producing plasmid.","volume":"13","author":"Dillon","year":"1999","journal-title":"Mol Cell Probes"},{"key":"R32-14-20210213","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jac\/dkp098","article-title":". Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes.","volume":"63","author":"Unemo","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R34-14-20210213","first-page":"32","article-title":". Phenotypic and molecular characterization of Neisseria gonorrhoeae isolated in Rio de Janeiro, Brazil, 2002-2003.","volume":"16","author":"Barreto","year":"2004","journal-title":"DST J Bras Doencas Sex Transm"},{"key":"R35-14-20210213","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/AAC.38.7.1688","article-title":"Susceptibility of Neisseria gonorrhoeae associated with pelvic inflammatory disease to cefoxitin, ceftriaxone, clindamycin, gentamicin, doxycycline, azithromycin, and other antimicrobial agents.","volume":"38","author":"Rice","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"R37-14-20210213","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1128\/JCM.01175-11","article-title":". Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil.","volume":"49","author":"Uehara","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R38-14-20210213","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1590\/S0074-02762011000500018","article-title":". Genotyping of two Neisseria gonorrhoeae fluoroquinolone-resistant strains in the Brazilian Amazon Region.","volume":"106","author":"Ferreira","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"R39-14-20210213","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/clinids\/20.Supplement_1.S47","article-title":"Drugs of choice for the treatment of uncomplicated gonococcal infections.","volume":"20","author":"Moran","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R41-14-20210213","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/OLQ.0b013e3181b61bb1","article-title":". Emergence of high level azithromycin-resistance Neisseria gonorrhoeae strain isolated in Argentina.","volume":"36","author":"Galarza","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R42-14-20210213","doi-asserted-by":"crossref","first-page":"ii","DOI":"10.2807\/ese.16.06.19792-en","article-title":"Ceftriaxone treatment failure of pharyngeal gonorrhea verified by international recommendations, Sweden, July 2010.","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill"},{"key":"R43-14-20210213","first-page":"370","article-title":"Notice to readers: discontinuation of spectinomycin.","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R44-14-20210213","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1056\/NEJM198707303170504","article-title":". Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing N. gonorrhoeae.","volume":"317","author":"Boslego","year":"1987","journal-title":"N Engl J Med"},{"key":"R45-14-20210213","first-page":"253","article-title":"Antimicrobial agents and gonorrhea: therapeutic choice, resistance and susceptibility testing.","volume":"72","author":"Ison","year":"1996","journal-title":"Genitourin Med"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/OLQ.0b013e3182631c9f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T15:45:56Z","timestamp":1745941556000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007435-201210000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e3182631c9f","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}